BLCO

BLCO

USD

Bausch + Lomb Corporation Common Shares

$15.550+0.080 (0.517%)

Prix en Temps Réel

Healthcare
Medical Instruments & Supplies
Canada

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$15.470

Haut

$15.554

Bas

$15.300

Volume

0.81M

Fondamentaux de l'Entreprise

Capitalisation Boursière

5.5B

Industrie

Medical Instruments & Supplies

Pays

Canada

Statistiques de Trading

Volume Moyen

0.52M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $10.45Actuel $15.550Haut $20.712

Actualités Connexes

BusinessWire

Bausch + Lomb to Hold Investor Day on Nov. 13

Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock

Voir plus
Bausch + Lomb to Hold Investor Day on Nov. 13
Analyst Upgrades

Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17

Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and raises the price target from $16 to $17.

Voir plus
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17

HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb with a Buy and raises the price target from $16 to $17.

Voir plus
HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16

JP Morgan analyst Robbie Marcus maintains Bausch & Lomb with a Neutral and raises the price target from $13 to $16.

Voir plus
JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16
Analyst Upgrades

Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18

Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb with a Outperform and raises the price target from $17 to $18.

Voir plus
Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18
Analyst Upgrades

Wells Fargo Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $16

Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb with a Equal-Weight and raises the price target from $15 to $16.

Analyst Upgrades

Raymond James Reiterates Outperform on Bausch & Lomb, Raises Price Target to $19

Raymond James analyst Gary Nachman reiterates Bausch & Lomb with a Outperform and raises the price target from $18 to $19.